Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 80
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03886688 | HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers | ||
| NCT03673696 | The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects | ||
| NCT04546984 | Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects | ||
| NCT07376200 | Single-ascending Dose Study of HEC-151 Injection | ||
| NCT05109078 | ADME Study of [14C]- Rongliflozin in Healthy Male Subjects | ||
| NCT05459285 | A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects | ||
| NCT05383131 | To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
| NCT05451602 | HEC169096 in Participants With Advanced Solid Tumors | ||
| NCT03502902 | The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects | ||
| NCT04925661 | HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia | ||
| NCT04551261 | GLS4/RTV and TAF Drug-drug Interaction | ||
| NCT04422496 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | ||
| NCT05374343 | A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment | ||
| NCT05127772 | A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing | ||
| NCT04536532 | Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study | ||
| NCT05504876 | Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114 | ||
| NCT03655873 | The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects | ||
| NCT05998304 | ADME Study of [14C] Yiqibuvir in Healthy Male Subjects | ||
| NCT04984512 | The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder | ||
| NCT03092102 | The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT03458481 | Phase 2 Study of Yimitasvir Phosphate Capsules | ||
| NCT07082842 | Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF | ||
| NCT04131192 | Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | ||
| NCT05057949 | A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants | ||
| NCT07341672 | A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants | ||
| NCT05492630 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects | ||
| NCT05059743 | ADME Study of [14C]- Larotinib in Healthy Male Subjects | ||
| NCT03487107 | Phase 3 Study of Yimitasvir Phosphate Capsules | ||
| NCT05048368 | Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function | ||
| NCT05497674 | Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects | ||
| NCT05391360 | Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study | ||
| NCT05133882 | A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML | ||
| NCT04201275 | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects | ||
| NCT04512170 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT04992858 | Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations | ||
| NCT04591301 | The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects | ||
| NCT03125876 | A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML) | ||
| NCT04565171 | Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD | ||
| NCT03758287 | Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative | ||
| NCT03943251 | The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects | ||
| NCT04415853 | Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer | ||
| NCT04324372 | Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors | ||
| NCT03462173 | The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects | ||
| NCT03638076 | The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules | ||
| NCT04596007 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects | ||
| NCT03662568 | A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects | ||
| NCT05802862 | A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China | ||
| NCT04625361 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects | ||
| NCT05060822 | Phase ll Study of HEC585 in Patients With IPF | ||
| NCT03663686 | The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects |
